Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

129
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
129
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

268
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
268
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

195
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
195
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

241
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
241
Standard Precaution01:26

Standard Precaution

2.6K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UNICORN TAVR in Native Complex Congenital Aortic Stenosis at High Risk of Coronary Obstruction.

JACC. Case reports·2026
Same author

Frailty as a predictor of delayed discharge and 12-month mortality following transcatheter aortic valve implantation.

Journal of geriatric cardiology : JGC·2026
Same author

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial.

Nature medicine·2026
Same author

Infective Endocarditis Risk After Invasive Dental Procedures.

Mayo Clinic proceedings. Innovations, quality & outcomes·2025
Same author

[2025 ESC/EACTS Guidelines for the management of valvular heart disease].

Giornale italiano di cardiologia (2006)·2025
Same author

Dedicated Versus Conventional Devices in Patients With Pure Native Aortic Regurgitation: A Systematic Review and Meta-Analysis.

Journal of the American Heart Association·2025

Related Experiment Video

Updated: Dec 12, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.2K

How to prevent infective endocarditis in 2020? Practical issues.

Jacob Brubert1, Thomas J Cahill2, Bernard D Prendergast3

  • 1Medical Sciences Division, University of Oxford, Oxford, United Kingdom

Kardiologia Polska
|August 14, 2020
PubMed
Summary

Infective endocarditis (IE) incidence is rising, with high mortality despite treatments. Prevention strategies targeting bacteremia, adhesion, and proliferation are crucial for at-risk patients.

More Related Videos

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

22.0K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

17.1K

Related Experiment Videos

Last Updated: Dec 12, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.2K
PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
06:36

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

22.0K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

17.1K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Infective endocarditis (IE) incidence is increasing globally, often linked to healthcare-associated staphylococcal infections.
  • Despite aggressive antibiotic therapy and surgical interventions, mortality rates for IE remain high, underscoring the need for effective prevention.

Purpose of the Study:

  • To review current strategies for preventing infective endocarditis.
  • To highlight the importance of targeting the pathogenic triad of IE: bacteremia, adhesion, and proliferation.
  • To discuss risk stratification for high-risk patients and procedures and the role of prophylactic antibiotics.

Main Methods:

  • Literature review of current infective endocarditis prevention strategies.
  • Analysis of risk factors, including implantable devices and high-risk procedures.
  • Examination of differing international guidelines on antibiotic prophylaxis.

Main Results:

  • Quantitative risk estimates can now identify high-risk patients and procedures for IE.
  • Novel coatings and designs for implantable devices show potential for risk reduction.
  • Global guidelines for pre- and periprocedural antibiotic use in IE prevention lack worldwide consensus.

Conclusions:

  • Preventing infective endocarditis requires a multifaceted approach targeting key points in the disease's pathogenesis.
  • Risk assessment and stratification are essential for guiding preventative strategies, including prophylactic antibiotics.
  • Further research and international consensus are needed to optimize IE prevention, particularly regarding antibiotic prophylaxis.